Literature DB >> 7292264

Prophylactic oophorectomy in operable instances of carcinoma of the breast.

A J Bryant, J A Weir.   

Abstract

In 1964, a prospective study was initiated of prophylactic oophorectomy in operable instances of carcinoma of the breast, in patients who showed evidence of ovarian activity. Patients were randomized to a control group and a group treated by surgical castration. By December 1979, 359 patients were evaluable at five years and 240 patients at ten years. The over-all results of the oophorectomy series were superior to that for those of the control group. Patients who had cancer confined to the breast showed no significant benefit from oophorectomy. When one to three axillary nodes were involved, women less than 50 years of age were found to benefit significantly from prophylactic oophorectomy, in relapse-free status at five years, and in survival and relapse-free status at ten years. Patients 50 years of age and older showed no advantage from oophorectomy. It s suggested that there is a place for prophylactic oophorectomy in patients who are less than 50 years of age with operable carcinoma of the breast and with positive axillary nodes.

Entities:  

Mesh:

Year:  1981        PMID: 7292264

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  8 in total

1.  Adjuvant oophorectomy versus CMF for premenopausal, node-positive, hormone receptor positive patients.

Authors:  W A Bethune
Journal:  J Natl Med Assoc       Date:  1991-08       Impact factor: 1.798

2.  Eight-year follow-up of adjuvant therapy for stage II breast cancer.

Authors:  C A Hubay; N H Gordon; O H Pearson; J S Marshall; W L McGuire
Journal:  World J Surg       Date:  1985-10       Impact factor: 3.352

Review 3.  Review of general surgery 1981.

Authors:  H Ellis
Journal:  Postgrad Med J       Date:  1982-06       Impact factor: 2.401

4.  Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast.

Authors:  J W Meakin; J L Hayward; T Panzarella; W E Allt; F A Beale; R D Bulbrook; R S Bush; R M Clark; P J Fitzpatrick; N V Hawkins; R D Jenkin; J F Pringle; W D Rider
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

5.  Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast.

Authors:  J W Meakin; W E Allt; F A Beale; R S Bush; R M Clark; P J Fitzpatrick; N V Hawkins; R D Jenkin; J F Pringle; J G Reid
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

Review 6.  WITHDRAWN: Ovarian ablation for early breast cancer.

Authors:  Mike J Clarke
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

7.  Host heterogeneity in female breast cancer: possible significance for pathophysiology, therapy, and prevention.

Authors:  P Cohen
Journal:  Breast Cancer Res Treat       Date:  1990-05       Impact factor: 4.872

8.  Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer.

Authors:  A R Bianco; L Del Mastro; C Gallo; F Perrone; E Matano; C Pagliarulo; S De Placido
Journal:  Br J Cancer       Date:  1991-05       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.